Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baihe Gujin tablets for chronic pharyngitis (lung–kidney yin deficiency)
ChiCTR2200060142Phase 4Not yet recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Gujin Granule in chronic pharyngitis (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: Clinical efficacy rate at day 14. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
Gujin Granule
03
Conditions
chronic pharyngitis
Beyond the preview
Go deeper on ChiCTR2200060142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060142.